Category:

FDA Approves Clinical Trial to Test Treating Fibromyalgia With TB Vaccine

By Erin Migdol, With the recent approval of the U.S. Food and Drug Administration (FDA), a human clinical trial is set to begin on BCG, a vaccine typically used to prevent tuberculosis, to treat fibromyalgia. BCG, or Bacillus Calmette-Guerin, has been used since 1921 as a TB vaccine in countries with a high prevalence of TB. […]

Continue Reading
Posted On :
Category:

How to Tell if it’s Fibromyalgia or Multiple Sclerosis

By Tiffany Vance-Huffman, There is so much mystery in the world of fibromyalgia, in large part because it effects everyone differently. Another reason for the mystery is due to the similarity in fibro symptoms compared to other diseases and syndromes. Fibromyalgia is sometimes misdiagnosed as a different problem and vice versa. This is because the […]

Continue Reading
Posted On :

FDA Approves Generic Duloxetine for Fibromyalgia-associated Pain and Depression

BY PATRICIA INACIO The U.S. Food and Drug Administration has approved Duloxetine, a generic version of Cymbalta (duloxetine), for treating fibromyalgia, depression, and anxiety, according to the generic’s maker, Solco Healthcare U.S. In addition to fibromyalgia, Duloxetine, the active ingredient in Cymbalta, is used to treat serious depression in adults, and anxiety in adults and children 7 years and older. Scientists say Duloxetine […]

Continue Reading
Posted On :
Category:

Fibromyalgia is Not All In Your Head, New Research Confirms

Fibromyalgia has been a mysterious disease, causing pain throughout the body and deep in tissues with no apparent cause. A large proportion of the medical community has believed that the disease was psychosomatic, and people essentially think that they are in pain. But a small biopharmaceutical company, Intidyn, or Integrated Tissue Dynamics, has found what they believe […]

Continue Reading
Posted On :
Category:

The benefits of cognitive behavioral therapy for fibromyalgia patients

According to Juan V. Luciano, Ph.D., a psychologist and researcher at Parc Sanitari Sant Joan de Déu in Barcelona, Spain said, “there is an agreement among the researchers that fibromyalgia syndrome may not be a single disease and the subcategories of the fibromyalgia patients may be identifiable.” He also adds, “Developing meaningful treatments that patients […]

Continue Reading
Posted On :